General information about company
Scrip code	524572
NSE Symbol	NOTLISTED
MSEI Symbol	NOTLISTED
ISIN	INE117D01018
Name of the entity	Pharmaids Pharmaceuticals Limited
Date of start of financial year	01-04-2025
Date of end of financial year	31-03-2026
Reporting Quarter Type	Quarterly
Date of Quarter Ending	31-12-2025
Type of company	Equity
Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity?	Yes
Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity?	Yes
Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity?	No	There are no acquisitions of shares or voting rights in unlisted Companies during the Quarter ended December 31, 2025.
Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity?	No	There are no penalties or fines imposed during the quarter ended December 31, 2025 in terms of sub-para 20 of para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity?	No	There are no tax litigations or disputes as on December 31, 2025, as per Annexure I (Part E) of the SEBI Circular dated December 31, 2024
Risk management committee	Not Applicable
Market Capitalisation as per immediate previous Financial Year	Any other
Is SCORE ID Available ?	Yes
SCORE Registration ID	P00115
Reason For No SCORE ID
Type of Submission	Original
Remarks (website dissemination)
Remarks for Exchange (not for Website Dissemination)

Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

Disclosure of notes on composition of board of directors explanatory

Textual Information(1)

Whether the listed entity has a Regular Chairperson

Yes

Whether Chairperson is related to MD or CEO

SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directors Date of Birth

VENU MADHAVA KAPARTHY

AAWPM7874Q

00021699

Executive Director

Not Applicable

11-07-1969

MINI MANIKANTAN

APYPM4112Q

09663184

Executive Director

Not Applicable

22-11-1984

SHANKARAPPA NAGARAJA VINAYA BABU

AEJPV9478A

01373832

Non-Executive - Non Independent Director

Not Applicable

14-10-1975

SHREEDHARA SHETTY

ABIPS7646D

02776638

Non-Executive - Non Independent Director

Not Applicable

05-03-1959

PATTAMADAI NATARAJASARMA VIJAY

AABPV0419M

00049992

Non-Executive - Independent Director

Chairperson

10-07-1951

METHUKU NAGESH

ABKPN5316R

01634324

Non-Executive - Independent Director

Not Applicable

16-06-1967

MOPPERTHY SUDHEER

ATWPS0062R

00404917

Non-Executive - Independent Director

Not Applicable

01-01-1974

I. Composition of Board of Directors

Disqualification of Directors under section 164 of the Companies Act, 2013

SrWhether the director is disqualified?Start Date of disqualificationEnd Date of disqualificationDetails of disqualificationCurrent status

Active

I. Composition of Board of Directors
Sr	Whether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations]	Date of passing special resolution	Initial Date of appointment	Date of Re-appointment	Date of cessation	Tenure of director (in months)	No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations)	No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & reg. 17A(2)]	Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations)	No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations)	Reason for Cessation	Notes for not providing PAN	Notes for not providing DIN
1	NA		21-05-2022	21-05-2025			1	0	2	0
2	NA		09-07-2022	09-07-2025			1	0	1	0
3	NA		31-01-2024				1	0	0	0
4	NA		29-08-2023				1	0	0	0
5	Yes	23-09-2025	31-10-2022	31-10-2022		38.01	2	2	3	2
6	NA		29-11-2022	29-11-2022		37.02	1	1	2	1
7	NA		29-09-2015	06-01-2021		123.02	1	1	1	0

Text Block

Textual Information(1)

Dr. S N Vinaya Babu, Chairman and Non-Executive & Non-Independent Director / Promoter of the Company, has expressed his desire to step down from the position of Chairman of the Board, and has requested to continue as Vice Chairman and Non-Executive & Non-Independent Director / Promoter of the Company. Considering the impending request and upon due consideration, based on the Recommendation of NRC, the Board of Directors has approved the appointment of Mr. Pattamadai Natarajasarma Vijay (P N Vijay) (DIN: 00047985), Independent Director, as the Chairman of the Board and the Company with effect from December 05, 2025, upto the conclusion of his term of appointment on October 30, 2027.

Annexure 1
II. Composition of Committees
Disclosure of notes on composition of committees explanatory				Textual Information(1)

Annexure 1 Text Block

Textual Information(1)

The change in the composition of the Nomination and Remuneration Committee (NRC) took effect on November 28, 2025. Mr. Methuku Nagesh, Non-Executive Independent Director of the Company, has been appointed as the Chairperson of the Nomination and Remuneration Committee. Mr. Pattamadai Natarajasarma Vijay (DIN: 00047985), Independent Director, ceased to be the Chairperson of the NRC and continues as a Member of the Committee. This change is pursuant to Mr. Pattamadai Natarajasarma Vijay being designated as the Chairman of the Board and the Company with effect from December 05, 2025. In terms of Regulation 19(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Chairperson of the Nomination and Remuneration Committee shall be an Independent Director and shall not be the Chairperson of the listed entity. Further, Dr. S. N. Vinaya Babu, Member of the Nomination and Remuneration Committee, ceased to be a Member of the Committee with effect from December 05, 2025.

Audit Committee Details
Whether the Audit Committee has a Regular Chairperson					Yes
Sr	DIN Number	Name of Committee members	Category 1 of directors	Category 2 of directors	Date of Appointment	Date of Cessation	Remarks
1	00021699	VENU MADHAVA KAPARTHY	Executive Director	Member	21-05-2022
2	01634324	METHUKU NAGESH	Non-Executive - Independent Director	Member	29-11-2022
3	00049992	PATTAMADAI NATARAJASARMA VIJAY	Non-Executive - Independent Director	Chairperson	29-11-2022
4	00404917	MOPPERTHY SUDHEER	Non-Executive - Independent Director	Member	04-08-2023

Nomination and remuneration committee
Whether the Nomination and remuneration committee has a Regular Chairperson					Yes
Sr	DIN Number	Name of Committee members	Category 1 of directors	Category 2 of directors	Date of Appointment	Date of Cessation	Remarks
1	01634324	METHUKU NAGESH	Non-Executive - Independent Director	Chairperson	29-11-2022		Textual Information(1)
2	00049992	PATTAMADAI NATARAJASARMA VIJAY	Non-Executive - Independent Director	Member	29-11-2022		Textual Information(2)
3	00404917	MOPPERTHY SUDHEER	Non-Executive - Independent Director	Member	29-08-2023
4	01373832	SHANKARAPPA NAGARAJA VINAYA BABU	Non-Executive - Non Independent Director	Member	28-05-2024	28-11-2025	Textual Information(3)

Sr Text Block
Textual Information(1)	Mr. Methuku Nagesh, Non-Executive Independent Director of the Company, has been appointed as the Chairperson of the Nomination and Remuneration Committee.
Textual Information(2)	Mr. Pattamadai Natarajasarma Vijay (DIN: 00047985), Independent Director, ceased to be the Chairperson of the NRC and continues as a Member of the Committee. This change is pursuant to Mr. Pattamadai Natarajasarma Vijay being designated as the Chairman of the Board and the Company with effect from December 05, 2025. In terms of Regulation 19(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Chairperson of the Nomination and Remuneration Committee shall be an Independent Director and shall not be the Chairperson of the listed entity.
Textual Information(3)	Dr. S. N. Vinaya Babu, Member of the Nomination and Remuneration Committee, ceased to be a Member of the Committee with effect from December 05, 2025.

Stakeholders Relationship Committee
Whether the Stakeholders Relationship Committee has a Regular Chairperson					Yes
Sr	DIN Number	Name of Committee members	Category 1 of directors	Category 2 of directors	Date of Appointment	Date of Cessation	Remarks
1	00021699	VENU MADHAVA KAPARTHY	Executive Director	Member	21-05-2022
2	09663184	MINI MANIKANTAN	Executive Director	Member	09-07-2022
3	01634324	METHUKU NAGESH	Non-Executive - Independent Director	Chairperson	29-11-2022

Risk Management Committee
Whether the Risk Management Committee has a Regular Chairperson
Sr	DIN Number	Name of Committee members	Category 1 of directors	Category 2 of directors	Date of Appointment	Date of Cessation	Remarks

Corporate Social Responsibility Committee
Whether the Corporate Social Responsibility Committee has a Regular Chairperson
Sr	DIN Number	Name of Committee members	Category 1 of directors	Category 2 of directors	Date of Appointment	Date of Cessation	Remarks

Other Committee
Sr	DIN Number	Name of Committee members	Name of other committee	Category 1 of directors	Category 2 of directors	Remarks

Annexure 1
Annexure 1
III. Meeting of Board of Directors
Disclosure of notes on meeting of board of directors explanatory
Sr. No.	Date(s) of meeting (if any) in the previous quarter	Date(s) of meeting (if any) in the current quarter	Maximum gap between any two consecutive (in number of days)	Notes for not providing Date	Whether requirement of Quorum met (Yes/No)	Total Number of Directors as on date of the meeting	Number of Directors present* (All directors including Independent Director)	No. of Independent Directors attending the meeting*
1	04-07-2025				Yes	7	6	2
2	07-08-2025		33		Yes	7	7	3
3	21-08-2025		13		Yes	7	7	3
4		11-11-2025	81		Yes	7	5	2

Annexure 1
IV. Meeting of Committees
Disclosure of notes on meeting of committees explanatory
Sr	Name of Committee	Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order)	Maximum gap between any two consecutive (in number of days)	Name of other committee	Reason for not providing date	Whether requirement of Quorum met (Yes/No)	Total Number of Directors in the Committee as on date of the meeting	Number of Directors Present (All Directors including Independent Director)	No. of Independent Directors attending the meeting*	No. of members attending the meeting (other than Board of Directors)
1	Audit Committee	04-07-2025				Yes	4	3	2	0
2	Audit Committee	07-08-2025	33			Yes	4	4	3	0
3	Audit Committee	21-08-2025	13			Yes	4	4	3	0
4	Audit Committee	11-11-2025	81			Yes	4	4	3	0
5	Nomination and remuneration committee	07-08-2025				Yes	4	4	3	0
6	Nomination and remuneration committee	21-08-2025	13			Yes	4	4	3	0

Annexure 1
IV. Meeting of Committees
Sr	Name of Committee	Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order)	Maximum gap between any two consecutive (in number of days)	Name of other committee	Reason for not providing date	Whether requirement of Quorum met (Yes/No)	Total Number of Directors in the Committee as on date of the meeting	Number of Directors Present (All Directors including Independent Director)	No. of Independent Directors attending the meeting*	No. of members attending the meeting (other than Board of Directors)
7	Stakeholders Relationship Committee	21-08-2025				Yes	3	3	1	0

Annexure 1
V. Affirmations
Sr	Subject	Compliance status (Yes/No)
1	The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015	Yes
2	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit Committee	Yes
3	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committee	Yes
4	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committee	Yes
5	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities)	NA
6	The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.	Yes
7	The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.	Yes
8	This report and/or the report submitted in the previous quarter has been placed before Board of Directors.	Yes

Annexure 1
Sr	Subject	Compliance status
1	Name of signatory	Prasanna Subramanya Bhat
2	Designation	Company Secretary and Compliance Officer

Details of Cyber security incidence
Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarter		No
Number of cyber security incidence or breaches or loss of data event occurred during the quarter
Sr.	Date of the event	Brief details of the event

Signatory Details
Name of signatory	Prasanna Subramanya Bhat
Designation of person	Company Secretary and Compliance Officer
Place	Bengaluru
Date	23-01-2026

Investor Grievance Details
No. of investor complaints pending at the beginning of Quarter	0
No. of investor complaints received during the Quarter	1
No. of investor complaints disposed off during the Quarter	1
No. of investor complaints those remaining unresolved at the end of the Quarter	0

General information about company

Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

I. Composition of Board of Directors

Disqualification of Directors under section 164 of the Companies Act, 2013

I. Composition of Board of Directors

Text Block

Annexure 1

II. Composition of Committees

Annexure 1 Text Block

Audit Committee Details

Nomination and remuneration committee

Sr Text Block

Stakeholders Relationship Committee

Risk Management Committee

Corporate Social Responsibility Committee

Other Committee

Annexure 1

Annexure 1

III. Meeting of Board of Directors

Annexure 1

IV. Meeting of Committees

Annexure 1

IV. Meeting of Committees

Annexure 1

V. Affirmations

Annexure 1

Details of Cyber security incidence

Signatory Details

Investor Grievance Details